Devon A. Lukow

Off-target toxicity is a common mechanism of action of cancer drugs undergoing clinical trials

A. Lin, Jason M. Sheltzer, Christopher J. Giuliano, 2019, Science Translational Medicine.

Oncogene-like addiction to aneuploidy in human cancers

R. Martienssen, Jason M. Sheltzer, Barbora Šalovská, 2023, bioRxiv.

Chromosomal instability accelerates the evolution of resistance to anti-cancer therapies

J. Kendall, Jason M. Sheltzer, Z. Storchová, 2020, bioRxiv.

Chromosomal instability and aneuploidy as causes of cancer drug resistance.

Jason M. Sheltzer, Devon A. Lukow, Devon A Lukow, 2021, Trends in cancer.